Patents by Inventor Hanlin TAO

Hanlin TAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mitochondrial uncouplers for treatment of metabolic diseases and cancer
    Patent number: 10525021
    Abstract: 2-hydroxy-benzoic anilide compounds and derivatives, compositions thereof, and methods for treating metabolic diseases and cancer through uncoupling mitochondria.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: January 7, 2020
    Assignee: Rutgers, the State University of New Jersey
    Inventors: Shengkan Jin, David J. Augeri, S. David Kimball, Peng Liu, Hanlin Tao, Xiangang Zeng
  • Mitochondrial uncouplers for treatment of metabolic diseases and cancer
    Patent number: 10227315
    Abstract: The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and methods of using the compounds, prodrugs and pharmaceutical compositions in the treatment of diseases related to lipid metabolism including diabetes, Non-Alcholic Fatty Liver Disease (NAFLD), Non-Alcholic Steathohepatitis (NASH), diseases caused by abnormal cell proliferation including cancer, psoriasis, and infectious diseases.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: March 12, 2019
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Shengkan Jin, David J. Augeri, Bin Cao, Hanlin Tao
  • NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER
    Publication number: 20170334869
    Abstract: The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and methods of using the compounds, prodrugs and pharmaceutical compositions in the treatment of diseases related to lipid metabolism including diabetes, Non-Alcholic Fatty Liver Disease (NAFLD), Non-Alcholic Steathohepatitis (NASH), diseases caused by abnormal cell proliferation including cancer, psoriasis, and infectious diseases.
    Type: Application
    Filed: May 18, 2017
    Publication date: November 23, 2017
    Inventors: Shengkan JIN, David J. AUGERI, Bin CAO, Hanlin TAO
  • NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER
    Publication number: 20170319516
    Abstract: 2-hydroxy-benzoic anilide compounds and derivatives, compositions thereof, and methods for treating metabolic diseases and cancer through uncoupling mitochondria.
    Type: Application
    Filed: November 18, 2015
    Publication date: November 9, 2017
    Inventors: Shengkan JIN, David J. AUGERI, David S. KIMBALL, Peng LIU, Hanlin TAO, Xiangang ZENG